Overview
Despite major advances in lung cancer care, clinicians continue to face challenges in treatment selection, sequencing, and toxicity management—especially as new data emerge across early- and advanced-stage disease. Incorporating evolving evidence, including updates on targeted therapies, immunotherapy, and multidisciplinary approaches, remains essential for optimizing patient outcomes.
The 24th Annual Winter Lung Cancer Conference® will offer an interactive, case-based curriculum led by expert faculty. The agenda will include discussions on lung cancer screening, perioperative strategies, immunotherapy, and targeted therapies. Through tumor boards, Medical Crossfire® sessions, and Q&A sessions, participants will gain practical insights to support real-world decision-making in lung cancer care.
Program Co-Chairs
Julie R. Brahmer, MD, MSc, FASCO; Edgardo S. Santos Castillero, MD, FACP, FASCO; Mark A. Socinski, MD
To view full profile, click on the Program Co-Chairs tab above.